Chunping Jiang

2.8k total citations
66 papers, 2.2k citations indexed

About

Chunping Jiang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chunping Jiang has authored 66 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 19 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Chunping Jiang's work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (7 papers). Chunping Jiang is often cited by papers focused on MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (7 papers). Chunping Jiang collaborates with scholars based in China, United States and Poland. Chunping Jiang's co-authors include Junhua Wu, Yitao Ding, Zhong‐Xia Wang, Xiwei Ding, Junyi Wu, Guang Zhang, Zhen Qu, Yin Cao, Dongjun Luo and Hesong Jiang and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Chunping Jiang

64 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunping Jiang China 27 1.3k 850 495 275 224 66 2.2k
Lianxin Liu China 27 1.4k 1.1× 1.1k 1.3× 533 1.1× 345 1.3× 226 1.0× 59 2.5k
Dae‐Ghon Kim South Korea 28 1.3k 1.0× 577 0.7× 365 0.7× 255 0.9× 156 0.7× 49 2.1k
Ye Cheng China 19 1.2k 0.9× 650 0.8× 283 0.6× 142 0.5× 275 1.2× 59 2.1k
Leina Ma China 24 1.6k 1.2× 793 0.9× 536 1.1× 149 0.5× 186 0.8× 50 2.2k
Meng Xia China 26 1.3k 1.0× 507 0.6× 397 0.8× 178 0.6× 314 1.4× 93 2.3k
Jie Ji China 21 1.2k 0.9× 766 0.9× 370 0.7× 134 0.5× 369 1.6× 74 2.1k
Keitaro Hagiwara Japan 20 1.8k 1.4× 1.3k 1.5× 277 0.6× 220 0.8× 235 1.0× 26 2.4k
Shu‐Xiang Cui China 24 1.0k 0.8× 546 0.6× 428 0.9× 115 0.4× 299 1.3× 69 1.8k
Guishuai Lv China 15 1.3k 1.0× 1.0k 1.2× 330 0.7× 107 0.4× 305 1.4× 18 2.0k

Countries citing papers authored by Chunping Jiang

Since Specialization
Citations

This map shows the geographic impact of Chunping Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunping Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunping Jiang more than expected).

Fields of papers citing papers by Chunping Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunping Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunping Jiang. The network helps show where Chunping Jiang may publish in the future.

Co-authorship network of co-authors of Chunping Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Chunping Jiang. A scholar is included among the top collaborators of Chunping Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunping Jiang. Chunping Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zeng, Zhen, Chunping Jiang, Fei Deng, et al.. (2025). Digestive characteristics of Tibetan tea polyphenols and polysaccharides in vitro and their effects on gut microbiota. Food Chemistry. 483. 144289–144289. 5 indexed citations
3.
Wang, Shuo, Linpei Wang, Yan Zhuang, et al.. (2025). Viral expression of NE/PPE enhances anti-colorectal cancer efficacy of oncolytic adenovirus by promoting TAM M1 polarization to reverse insufficient effector memory/effector CD8+ T cell infiltration. Journal of Experimental & Clinical Cancer Research. 44(1). 97–97. 8 indexed citations
4.
Xue, Bin, Louqian Zhang, Shuo Wang, et al.. (2025). In situ extended immune activation instantly after tumor resection by oncolytic virus controls postoperative tumor recurrence. Cell Reports Medicine. 6(10). 102399–102399.
5.
Zhang, Louqian, Yan Zhuang, Jinqiu Tao, et al.. (2024). Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy. Cell Reports Medicine. 5(10). 101751–101751. 10 indexed citations
6.
Zhang, Louqian, et al.. (2024). “Find Me” and “Eat Me” signals: tools to drive phagocytic processes for modulating antitumor immunity. Cancer Communications. 44(7). 791–832. 28 indexed citations
7.
Wu, Junyi, Xiangjie Xu, Shasha Wu, et al.. (2023). UBE2S promotes malignant properties via VHL/HIF‐1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma. Cancer Medicine. 12(17). 18078–18097. 7 indexed citations
8.
Zhuang, Yan, et al.. (2023). Hypoxia signaling in cancer: Implications for therapeutic interventions. SHILAP Revista de lepidopterología. 4(1). e203–e203. 67 indexed citations
9.
Gu, Xiaosong, et al.. (2023). The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies. Cell & Bioscience. 13(1). 188–188. 26 indexed citations
10.
11.
Zhou, Yan, et al.. (2023). High endothelial venule is a prognostic immune‐related biomarker in patients with resected intrahepatic cholangiocarcinoma. Cell Proliferation. 56(12). e13513–e13513. 12 indexed citations
12.
Chen, Weibo, Junyi Wu, Weiwei Shi, et al.. (2021). PRRX1 deficiency induces mesenchymal‐epithelial transition through PITX2/miR‐200–dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma. Cancer Science. 112(6). 2158–2172. 10 indexed citations
13.
Xu, C. F., Jie Dong, Shuguang Zuo, et al.. (2020). Liraglutide activates nature killer cell-mediated antitumor responses by inhibiting IL-6/STAT3 signaling in hepatocellular carcinoma. Translational Oncology. 14(1). 100872–100872. 26 indexed citations
14.
Shi, Weiwei, Shan Zhang, Ding Ma, et al.. (2020). Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma. Frontiers in Oncology. 10. 694–694. 39 indexed citations
15.
Zhang, Guang, Zhong‐Xia Wang, Weibo Chen, et al.. (2019). Dual effects of gossypol on human hepatocellular carcinoma via endoplasmic reticulum stress and autophagy. The International Journal of Biochemistry & Cell Biology. 113. 48–57. 7 indexed citations
16.
Li, Binghua, et al.. (2018). The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 102. 420–427. 24 indexed citations
17.
Luo, Dongjun, et al.. (2014). The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma. BioMed Research International. 2014. 1–11. 127 indexed citations
18.
Liu, Baorui, Fangbo Cui, Qin Liu, et al.. (2014). Enhancement of radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer cells. International Journal of Nanomedicine. 9. 2345–2345. 31 indexed citations
19.
Chen, Weibo, Zhong‐Xia Wang, Chunping Jiang, & Yitao Ding. (2013). PP2A-Mediated Anticancer Therapy. Gastroenterology Research and Practice. 2013. 1–10. 46 indexed citations
20.
Jiang, Chunping, et al.. (2011). Immunohistochemical study of gastrin in colorectal carcinoma tissues and adjacent mucosa. World Journal of Gastroenterology. 3(2). 84–84.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lianxin Liu Breakdown of academic impact, for papers by Dae‐Ghon Kim Breakdown of academic impact, for papers by Ye Cheng Breakdown of academic impact, for papers by Leina Ma Breakdown of academic impact, for papers by Meng Xia Breakdown of academic impact, for papers by Jie Ji Breakdown of academic impact, for papers by Keitaro Hagiwara Breakdown of academic impact, for papers by Shu‐Xiang Cui Breakdown of academic impact, for papers by Guishuai Lv
Rankless by CCL
2026